Presentation TVT 2023 LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials Presenter: Paul Sorajja June 09, 2023
Presentation TVT 2023 Update From the Clinical Trials and Where I Would and Wouldn’t Use It Presenter: Basel Ramlawi June 08, 2023
Presentation TVT 2023 Update From the Clinical Trials and Where I Would and Wouldn’t Use It Presenter: Azeem Latib June 08, 2023
Presentation TVT 2023 Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital Presenter: Lu Chen June 08, 2023
Presentation TVT 2022 TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials Presenter: Mahesh V. Madhavan June 10, 2022
Presentation TVT 2022 Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky June 10, 2022
Presentation TVT 2022 Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials Presenter: Ashwin Nathan June 08, 2022
Presentation TVT 2022 First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials Presenter: Georg Nickenig June 08, 2022
Presentation TVT 2022 Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials Presenter: Ori Ben-Yehuda June 08, 2022
Presentation TVT 2022 From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All! Presenter: Sreekanth Vemulapalli June 08, 2022
Presentation TVT 2022 Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials Presenter: Yousif Ahmad June 08, 2022
Presentation TVT 2021 Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Presenter: Yousif Ahmad July 22, 2021
Presentation TVT 2021 Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices Presenter: JoAnn Lindenfeld July 22, 2021
Presentation TVT 2021 How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices Presenter: Susan M. Joseph July 22, 2021
Presentation TVT 2021 Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions Presenter: Samir Kapadia July 21, 2021
Presentation TVT 2020 First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation Presenter: Hasan Jilaihawi June 21, 2020
Presentation TVT 2019 Mitral Valve-In… -Valve and -Ring I: Insights From the Registries/Trials Presenter: Mayra Guerrero June 14, 2019
Presentation TVT 2019 Valve Performance and Durability After Transcatheter Versus Surgical Aortic Valve Replacement — A Meta-Analysis of Randomized Controlled Trials Presenter: Ankur Sethi June 14, 2019
Presentation TVT 2019 Which Patients Are Best Candidates for Clinical Trials With… Transcatheter Mitral Valve Replacement (Anatomic and Clinical Factors) Presenter: Thomas Modine June 14, 2019
Presentation TVT 2019 Which Patients Are Best Candidates for Clinical Trials With… Transcatheter Leaflet/Chordal Suspension (Anatomic and Clinical Factors) Presenter: Steven Bolling June 14, 2019